Gmt Capital Corp Biogen Inc. Transaction History

Gmt Capital Corp

$2.38 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $7.25 Million - $8.62 Million	-38,650 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $1.01 Million - $1.27 Million	-5,200 Reduced 11.86%	38,650 $8.14 Million
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $877,269 - $1.14 Million	-3,100 Reduced 6.6%	43,850 $12.4 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $3.79 Million - $6.06 Million	-14,620 Reduced 23.75%	46,950 $16.3 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $3.06 Million - $3.59 Million	-12,600 Reduced 16.99%	61,570 $17.2 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $1.23 Million - $1.85 Million	-5,200 Reduced 6.55%	74,170 $18.2 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $13.6 Million - $15.7 Million	-51,500 Reduced 39.35%	79,370 $22.5 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $41.4 Million - $54.8 Million	-160,100 Reduced 55.02%	130,870 $35 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $3.66 Million - $4.64 Million	13,600 Added 4.9%	290,970 $92.1 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $4.02 Million - $5.56 Million	18,280 Added 7.06%	277,370 $82.3 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $10.5 Million - $11.8 Million	-48,230 Reduced 15.69%	259,090 $60.3 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $13.9 Million - $15.3 Million	-63,340 Reduced 17.09%	307,320 $71.9 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $1.36 Million - $2.13 Million	6,290 Added 1.73%	370,660 $87.6 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $5.8 Million - $7.34 Million	20,820 Added 6.06%	364,370 $110 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $4.95 Million - $6.47 Million	-16,850 Reduced 4.68%	343,550 $121 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $9.27 Million - $11 Million	36,000 Added 11.1%	360,400 $105 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $1.38 Million - $1.95 Million	5,300 Added 1.66%	324,400 $88.8 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $8 Million - $8.96 Million	26,000 Added 8.87%	319,100 $102 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $11.5 Million - $13.5 Million	40,900 Added 16.22%	293,100 $91.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	252,200	252,200 $69.1 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.23 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.18 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.83 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.38 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.11 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Gmt Capital Corp with notifications on news.

Account